Rxivist logo

Endogenous BioID elucidates TCF7L1 interactome modulation upon GSK-3 inhibition in mouse ESCs

By Steven Moreira, Caleb Seo, Victor Gordon, Sansi Xing, Ruilin Wu, Enio Polena, Vincent Fung, Deborah Ng, Cassandra J Wong, Brett Larsen, Brian Raught, Anne-Claude Gingras, Yu Lu, Bradley W. Doble✉

Posted 01 Oct 2018
bioRxiv DOI: 10.1101/431023

Modulation of Wnt target gene expression via the TCF/LEFs remains poorly understood. We employ proximity-based biotin labeling (BioID) to examine GSK-3 inhibitor effects on the TCF7L1 interactome in mouse ESCs. We generated ESC lines with biotin ligase BirA* fused to TCF7L1 by knocking it into the endogenous TCF7L1 locus or by inserting a dox-inducible BirA*-TCF7L1 transgene into the Rosa26 locus. Induction yielded BirA*-TCF7L1 levels 3-fold higher than in the endogenous system, but substantial overlap in biotinylated proteins with high peptide counts were detected by each method. Known TCF7L1 interactors TLE3/4 and β-catenin, and numerous proteins not previously associated with TCF7L1, were identified in both systems. Despite reduced BirA*-TCF7L1 levels, the number of hits identified with both BioID approaches increased after GSK-3 inhibition. We elucidate the network of TCF7L1 proximal proteins regulated by GSK-3 inhibition, validate the utility of endogenous BioID, and provide mechanistic insights into TCF7L1 target gene regulation.

Download data

  • Downloaded 971 times
  • Download rankings, all-time:
    • Site-wide: 19,530
    • In cell biology: 664
  • Year to date:
    • Site-wide: 81,421
  • Since beginning of last month:
    • Site-wide: 47,436

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News